SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-012064
Filing Date
2023-04-06
Accepted
2023-04-06 16:05:48
Documents
3
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A elym-def_14a-2023_proxy.htm DEF 14A 969615
2 GRAPHIC img163911241_0.jpg GRAPHIC 1312261
3 GRAPHIC img163911241_1.jpg GRAPHIC 745034
  Complete submission text file 0000950170-23-012064.txt   3803228
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40708 | Film No.: 23806191
SIC: 2834 Pharmaceutical Preparations